Preclinical Drug Efficacy Evaluation Services

Humanized Mouse Disease Models for Preclinical Testing of biologics, small molecules, novel therapeutic treatments

We are a CRO offering in vivo and ex vivo preclinical drug efficacy evaluation services using a diverse array of proprietary mouse disease models that carry humanized targets such as TNF, TNFR1, IL17, IL23A, IL12B, RANKL and others. Our mouse models closely recapitulate the pathology and complexity of human diseases including Rheumatoid Arthritis, Spondyloarthriits, Psoriasis, Osteoporosis, Intestinal Inflammation, Lupus, Idiopathic Pulmonary Fibrosis, Acute Inflammation, Infectious Diseases, Multiple Sclerosis and Cancer.